IndraLab

Statements

USP1 inhibits cisplatin. 2 / 2
| 2
reach
"This view has gained recent support with the finding that USP1 inhibition may contribute to revert cisplatin resistance in an in vitro model of non small cell lung cancer (NSCLC)."
23937906
reach
"These findings are consistent with those of Chen et al. [XREF_BIBR], and suggest that USP1 inhibition may contribute to revert cisplatin resistance in some preclinical models of NSCLC."
23937906